Literature DB >> 6966934

Immunological aspects of psoriasis. IV. Presence of circulating immune complexes in patients before and after PUVA therapy; correlations with T-cell markers.

J J Guilhou, J Clot, B Guillot, M Andary, J Meynadier.   

Abstract

We investigated sixteen patients before and after 1 month of PUVA therapy (three times a week) for circulating immune complexes (CIC) and T-cell markers. CIC were detected by the PEG-C4 assay, using a laser nephelometry determination of polyethylene glycol (PEG, 3.5%) precipitated endogenous C4. T cells were evaluated by E rosettes, active E rosettes, anti-HTLA serum and ox EA gamma-rosettes. This latter method investigated mainly T cells bearing Fc receptors for IgG (Tgamma-cells). After 1 month of PUVA-therapy: (a) the cutaneous lesions markedly improved; (b) the mean percentages of E rosettes, active E rosettes, and HTLA bearing cells, depressed before treatment, returned to normal; (c) CIC were found in higher amounts; (d) T gamma-cell numbers decreased simultaneously. The improvement of T-cell levels assessed by E rosettes, active E rosettes and HTLA values was correlated with clearing of skin lesions, as previously reported by others. However, the increase of CIC during PUVA therapy, their correlation with T gamma-cell decrease, and their possible role in the pathogenic chain of psoriasis remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966934     DOI: 10.1111/j.1365-2133.1980.tb05689.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.

Authors:  B Guillot; M Coupe; M Alirezai; J P Bureau; J J Guilhou
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Circulating immune complexes in untreated psoriasis. A comparison of Raji-cell radioimmunoassay and polymorphonuclear leukocyte phagocytosis.

Authors:  L Lindholm; H Mobacken; B L Magnusson
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  The N-terminal amino acid sequence of the psoriasis-associated antigen, pso p27.

Authors:  O J Iversen; H Lysvand; K Bergh; J Eriksen; S Elsayed
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 4.  Immunopathology of psoriasis.

Authors:  R H Cormane
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

5.  PUVA therapy for psoriasis.

Authors:  H Baker
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

6.  Immunofluorescence in psoriasis: studies of immunoglobulins, complement deposits, and three membrane markers.

Authors:  J J Guilhou; S Malbos; D Delalleau; J Meynadier
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

Review 7.  Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?

Authors:  B Lindelöf
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.